Figure 5. Effect of anti-VEGF pretreatment on corneal neovascularization during fungal keratitis. Relative severity of corneal neovascularization (NV) during 7 days of follow up in C. albicans keratitis in mice treated with intraperitoneal VEGF-blocking antibody B20-4.1.1 (anti-VEGF) compared to controls receiving phosphate-buffered saline (PBS). Each point reprsents the mean neovascularization score (±SD) of 5 eyes at each day following topical inoculation. Asterisks indicate time points having a statistically significant (p<0.01) difference.